Skip to left navigation

Skip to page content

Find us on...

The Malvern NanoSight range of instruments utilizes Nanoparticle Tracking Analysis (NTA) to characterize nanoparticles from 10nm -2000nm* in solution. Each particle is individually but simultaneously analyzed by direct observation and measurement of diffusion events. This particle-by-particle methodology produces high resolution results for particle size distribution and concentration, while visual validation provides users with additional confidence in their data. Both particle size and concentration are measured, while a fluorescence mode provides differentiation of labelled or naturally fluorescing particles.

* sample dependent

NanoSight NS300 Optimized for fluorescence work. NanoSight range - measurement of exosomes, nanoparticles and protein aggregation
Measurement
Particle size, Particle concentration, Protein aggregation
Particle size range
10nm to 2000nm
Technology
Nanoparticle Tracking Analysis
More information
NanoSight NS500 Single particle zeta potential platform with integrated fluidics for automation. NanoSight NS500 single particle size distribution, fluorescence, zeta potential measurment
Measurement
Particle size, Particle concentration, Protein aggregation, Zeta potential
Particle size range
10nm to 2000nm
Technology
Nanoparticle Tracking Analysis, Electrophoretic Light Scattering
More information
NanoSight LM10 Affordable, highly flexible format with interchangeable lasers. Image
Measurement
Particle size, Particle concentration, Protein aggregation
Particle size range
10nm to 2000nm
Technology
Nanoparticle Tracking Analysis
More information
 
 

Resource center search

Free access to exclusive content including webinars, presentations, application notes, technical notes, whitepapers and more. Enter your search term in the box and use the drop down boxes to filter the results.

Reset filters
Items shown: 5, 10, 20, ALL
Sort by: Date or Alphabetical
Previous page Showing results 1 - 5 of 103 Next page
Applying complementary particle techniques for assessing comparability and biosimilarity of therapeutic products Webinar - Live (English)

Significant advances have been made in analytical technology for the characterization and identification of particles present in pharmaceutical products. With these advances comes a tremendous amount of new data with which to characterize biologics, ...

Product:
Archimedes,Zetasizer range,Viscotek SEC-MALS,Morphologi G3-ID,NanoSight range
Date:
September 20 2016
Language:
English


NanoSight NS500 Zeta Potential Analysis Technical Note (English)

NanoSight NS500 Zeta Potential Analysis Flow Chart for Use with NTA Software Versions 3.1 and 3.2



Monitoring Microfiltration Processes for Water Treatment Application Note (English)

With the increasing demands on water supplies and tighter regulations, much research is being done on water treatment processes. Subjects of study include improving processes to allow treated water to be used in secondary applications, optimizing fil...



Adeno-Associated Viral Titer in minutes, using Nanoparticle Tracking Analysis (NTA) Webinar - Recorded (English)

• Nanoparticle Tracking Analysis (NTA) Characterization of Gold-Labeled Adeno Associated Virus (AAV) and Other Small Viruses • NTA is an analytical tool that measures the size and concentration of virus particles. • NTA can measure virus titer in abo...

Product:
NanoSight range
Date recorded:
June 7 2016
Language:
English


Case study: Using NTA to study nanoparticle diffusion Webinar - Recorded (English)

• Nanoparticle Tracking Analysis (NTA) was used to study the diffusion of silica nanoparticles functionalized with different polymers in aqueous solutions of water-soluble polymers and in dispersions of porcine gastric mucin • It was found that th...

Product:
NanoSight range
Date recorded:
May 24 2016
Language:
English

Previous page Showing results 1 - 5 of 103 Next page

Glossary

Request a quote Request a demo Contact sales Register now Download brochure
 

Upcoming webinar

Applying complementary particle techniques for assessing comparability and biosimilarity of therapeutic products
(September 20 2016)

More information